D3T-21024-02426
3 vaccinations
7 coded responses
25 check-ins
7 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 923 / CA
- Registered
- 2021-03-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-17
Registered in v-safe
-
2021-03-17
Dose 1 — Pfizer-BioNTech
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-20
-
2021-03-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-23
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-25
Health check-in — day 7, dose 1Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-31
-
2021-04-07
Dose 2 — Pfizer-BioNTech
-
2021-04-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-04-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2021-04-10
Survey response — days 1–6 daily, dose 2MedDRA: Pain — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Worsening of chronic pain & muscle pain & spasms especially in legs & neckMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-11
Survey response — days 1–6 daily, dose 2MedDRA: Condition aggravated, Muscle spasms, Pain, Pre-existing disease — Feeling: Fair · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Pain level and spasms have stayed worse than ususlMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2021-04-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-14
Health check-in — day 7, dose 2Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-21
Survey response — day 14, dose 2MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: At least daily Headaches, with both pain level and duration worsening. On two occasions I have had more than one headache in a 24 hr period.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-29
- 2021-05-06
- 2021-05-13
-
2021-05-20
Survey response — day 42, dose 2MedDRA: Urinary tract infection — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: UTI, onset 5/17.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-20
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-07
Survey response — 3 months, dose 2MedDRA: Muscle spasms, Myalgia — Feeling: FairFree text: Intermittent muscle cramps upper and lower extremities. Cramps are painful.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-10-07
Survey response — 6 months, dose 2MedDRA: Adverse reaction, Sinusitis — Feeling: GoodFree text: Sinusitis and increased allergy symptoms.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-24
Dose 3 — Pfizer-BioNTech
-
2022-04-08
Survey response — 12 months, dose 2MedDRA: Localised infection, Peripheral swelling — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Possible Pneumonia L Lung, Possible Partially collapsed R Lung under the R Diaphragm L Lower leg infection and significant Swelling/ Triple Antibiotics requiredMedDRA releases: 2024-11 · check-in free text available
-
2022-04-08
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-04-12
- 2022-05-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-17 | Pfizer-BioNTech | |
| 2 | 2021-04-07 | Pfizer-BioNTech | |
| 3 | 2021-11-24 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Worsening of chronic pain & muscle pain & spasms especially in legs & neck
Systemic reaction (other): Pain level and spasms have stayed worse than ususl
Release 7 — day 14, dose 2
Symptoms: At least daily Headaches, with both pain level and duration worsening. On two occasions I have had more than one headache in a 24 hr period.
Release 8 — day 42, dose 2
Symptoms: UTI, onset 5/17.
Release 9 — 3 months, dose 2
Symptoms: Intermittent muscle cramps upper and lower extremities. Cramps are painful.
Release 10 — 6 months, dose 2
Symptoms: Sinusitis and increased allergy symptoms.
Release 11 — 12 months, dose 2
Symptoms: Possible Pneumonia L Lung, Possible Partially collapsed R Lung under the R Diaphragm L Lower leg infection and significant Swelling/ Triple Antibiotics required
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Adverse reaction | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Localised infection | · | · | ✓ |
| SD | Muscle spasms | ✓ | ✓ | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Peripheral swelling | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Urinary tract infection | ✓ | ✓ | ✓ |
| SRO | Condition aggravated | ✓ | ✓ | ✓ |
| SRO | Muscle spasms | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release